Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC)

N. Biglia, F. Maggiorotto, V. Liberale, V. E. Bounous, L. G. Sgro, S. Pecchio, M. D'Alonzo, R. Ponzone

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Purpose of the study: A retrospective analysis on 1407 patients with invasive ductal carcinoma (IDC) and 243 invasive lobular carcinoma (ILC) was performed in order to compare the histological features, the immunohistochemical characteristics, the surgical treatment and the clinical outcome in the two groups. Results: ILC seems to be more likely multifocal, estrogen receptor positive, HER-2 negative and to have a lower proliferative index compared to IDC. ILC, when treated with conservative surgery, required more frequently re-excision and/or mastectomy because of positive resection margins. No difference was observed in terms of 5-year disease free survival and local relapse free survival between the two groups, in the whole series and in the subgroup of patients treated with breast-conserving treatment. Conclusion: ILC can be safely treated with conservative surgery but a more accurate preoperative evaluation of tumor size and multifocality could be advocated, in order to reduce the re-excision rate.

Original languageEnglish
Pages (from-to)455-460
Number of pages6
JournalEuropean Journal of Surgical Oncology
Volume39
Issue number5
DOIs
Publication statusPublished - May 2013

Fingerprint

Lobular Carcinoma
Ductal Carcinoma
Mastectomy
Estrogen Receptors
Disease-Free Survival
Breast
Retrospective Studies
Recurrence
Survival
Neoplasms

Keywords

  • Breast cancer
  • Breast cancer prognosis
  • Breast conserving treatment
  • Infiltrating ductal carcinoma
  • Infiltrating lobular carcinoma
  • Surgical treatment

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). / Biglia, N.; Maggiorotto, F.; Liberale, V.; Bounous, V. E.; Sgro, L. G.; Pecchio, S.; D'Alonzo, M.; Ponzone, R.

In: European Journal of Surgical Oncology, Vol. 39, No. 5, 05.2013, p. 455-460.

Research output: Contribution to journalArticle

@article{8ee97b671f80464ab7a1fa127f0d1008,
title = "Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC)",
abstract = "Purpose of the study: A retrospective analysis on 1407 patients with invasive ductal carcinoma (IDC) and 243 invasive lobular carcinoma (ILC) was performed in order to compare the histological features, the immunohistochemical characteristics, the surgical treatment and the clinical outcome in the two groups. Results: ILC seems to be more likely multifocal, estrogen receptor positive, HER-2 negative and to have a lower proliferative index compared to IDC. ILC, when treated with conservative surgery, required more frequently re-excision and/or mastectomy because of positive resection margins. No difference was observed in terms of 5-year disease free survival and local relapse free survival between the two groups, in the whole series and in the subgroup of patients treated with breast-conserving treatment. Conclusion: ILC can be safely treated with conservative surgery but a more accurate preoperative evaluation of tumor size and multifocality could be advocated, in order to reduce the re-excision rate.",
keywords = "Breast cancer, Breast cancer prognosis, Breast conserving treatment, Infiltrating ductal carcinoma, Infiltrating lobular carcinoma, Surgical treatment",
author = "N. Biglia and F. Maggiorotto and V. Liberale and Bounous, {V. E.} and Sgro, {L. G.} and S. Pecchio and M. D'Alonzo and R. Ponzone",
year = "2013",
month = "5",
doi = "10.1016/j.ejso.2013.02.007",
language = "English",
volume = "39",
pages = "455--460",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC)

AU - Biglia, N.

AU - Maggiorotto, F.

AU - Liberale, V.

AU - Bounous, V. E.

AU - Sgro, L. G.

AU - Pecchio, S.

AU - D'Alonzo, M.

AU - Ponzone, R.

PY - 2013/5

Y1 - 2013/5

N2 - Purpose of the study: A retrospective analysis on 1407 patients with invasive ductal carcinoma (IDC) and 243 invasive lobular carcinoma (ILC) was performed in order to compare the histological features, the immunohistochemical characteristics, the surgical treatment and the clinical outcome in the two groups. Results: ILC seems to be more likely multifocal, estrogen receptor positive, HER-2 negative and to have a lower proliferative index compared to IDC. ILC, when treated with conservative surgery, required more frequently re-excision and/or mastectomy because of positive resection margins. No difference was observed in terms of 5-year disease free survival and local relapse free survival between the two groups, in the whole series and in the subgroup of patients treated with breast-conserving treatment. Conclusion: ILC can be safely treated with conservative surgery but a more accurate preoperative evaluation of tumor size and multifocality could be advocated, in order to reduce the re-excision rate.

AB - Purpose of the study: A retrospective analysis on 1407 patients with invasive ductal carcinoma (IDC) and 243 invasive lobular carcinoma (ILC) was performed in order to compare the histological features, the immunohistochemical characteristics, the surgical treatment and the clinical outcome in the two groups. Results: ILC seems to be more likely multifocal, estrogen receptor positive, HER-2 negative and to have a lower proliferative index compared to IDC. ILC, when treated with conservative surgery, required more frequently re-excision and/or mastectomy because of positive resection margins. No difference was observed in terms of 5-year disease free survival and local relapse free survival between the two groups, in the whole series and in the subgroup of patients treated with breast-conserving treatment. Conclusion: ILC can be safely treated with conservative surgery but a more accurate preoperative evaluation of tumor size and multifocality could be advocated, in order to reduce the re-excision rate.

KW - Breast cancer

KW - Breast cancer prognosis

KW - Breast conserving treatment

KW - Infiltrating ductal carcinoma

KW - Infiltrating lobular carcinoma

KW - Surgical treatment

UR - http://www.scopus.com/inward/record.url?scp=84876408434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876408434&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2013.02.007

DO - 10.1016/j.ejso.2013.02.007

M3 - Article

C2 - 23490334

AN - SCOPUS:84876408434

VL - 39

SP - 455

EP - 460

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 5

ER -